ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Esomeprazole Magnesium Delayed-Release Capsules
Mapping Intimacies
◽
10.31003/uspnf_m30590_05_01
◽
2021
◽
Keyword(s):
Delayed Release
◽
Esomeprazole Magnesium
Download Full-text
Related Documents
Cited By
References
Formulation and Evaluation of Esomeprazole Magnesium delayed release Tablets 40MG
International Journal of Research and Applications
◽
10.17812/ijra.2.6(45)2015
◽
2015
◽
Vol 2
(6)
◽
pp. 242-252
Author(s):
Jagadeesh Kumar Ega
Keyword(s):
Delayed Release
◽
Esomeprazole Magnesium
Download Full-text
Prediction of In-vivo Performance of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets using Biorelevant Dissolution Tests
Asian Journal of Pharmaceutical Research and Health Care
◽
10.18311/ajprhc/2020/25237
◽
2020
◽
Vol 12
(2)
◽
pp. 12-23
Author(s):
Devi Thamizhanban
◽
Gampa Tulja Rani
◽
Kathiresan Krishnasamy
◽
◽
◽
...
Keyword(s):
Delayed Release
◽
Biorelevant Dissolution
◽
Dissolution Tests
◽
Esomeprazole Magnesium
Download Full-text
In Vitro Evaluation of Nasogastric Tube Delivery Performance of Esomeprazole Magnesium Delayed-Release Capsules
Journal of Pharmaceutical Sciences
◽
10.1016/j.xphs.2017.04.008
◽
2017
◽
Vol 106
(7)
◽
pp. 1859-1864
◽
Cited By ~ 3
Author(s):
Alicia Hoover
◽
Dajun Sun
◽
Hong Wen
◽
Wenlei Jiang
◽
Minglei Cui
◽
...
Keyword(s):
Nasogastric Tube
◽
In Vitro Evaluation
◽
Delivery Performance
◽
Delayed Release
◽
Esomeprazole Magnesium
Download Full-text
Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies
Journal of Thrombosis and Thrombolysis
◽
10.1007/s11239-013-1035-4
◽
2013
◽
Vol 38
(1)
◽
pp. 11-23
◽
Cited By ~ 11
Author(s):
Dominick J. Angiolillo
◽
Catherine Datto
◽
Shane Raines
◽
Neville D. Yeomans
Keyword(s):
Drug Therapy
◽
Low Dose
◽
Phase Iii
◽
Inflammatory Drug
◽
Delayed Release
◽
Dose Aspirin
◽
Low Dose Aspirin
◽
Anti Inflammatory
◽
Esomeprazole Magnesium
◽
Phase Iii Studies
Download Full-text
Oral azathioprine delayed-release (AZA-DR) delivers AZA to the ileum/colon with less systemic exposure than occurs with imuran®
Gastroenterology
◽
10.1016/s0016-5085(01)83108-5
◽
2001
◽
Vol 120
(5)
◽
pp. A625-A625
Author(s):
B HEPBURN
◽
B GOLDLUST
◽
C LUBIN
Keyword(s):
Systemic Exposure
◽
Delayed Release
Download Full-text
Patanase Nasal Spray, Prilosec Delayed- Release Oral Suspension
Pediatric News
◽
10.1016/s0031-398x(08)70230-3
◽
2008
◽
Vol 42
(5)
◽
pp. 31
Author(s):
DAMIAN MCNAMARA
Keyword(s):
Nasal Spray
◽
Oral Suspension
◽
Delayed Release
Download Full-text
Lodotra (delayed release prednisone) is variably absorbed, and should not be used in adrenal insufficiency
Endocrine Abstracts
◽
10.1530/endoabs.50.p186
◽
2017
◽
Author(s):
Jennifer Zhang
◽
Sirazum Choudhury
◽
Karim Meeran
Keyword(s):
Adrenal Insufficiency
◽
Delayed Release
Download Full-text
Delayed-release dimethyl fumarate demonstrated no evidence of difference in clinical outcomes vs fingolimod in patients with RRMS: a propensity-matched comparative effectiveness analysis of the German NeuroTransData registry
10.26226/morressier.59a3eda8d462b8028d895362
◽
2017
◽
Author(s):
Stefan Braune
Keyword(s):
Clinical Outcomes
◽
Comparative Effectiveness
◽
Dimethyl Fumarate
◽
Delayed Release
◽
Effectiveness Analysis
◽
Comparative Effectiveness Analysis
Download Full-text
Efficacy of Delayed-release Dimethyl Fumarate in Newly Diagnosed Patients With Relapsing-Remitting Multiple Sclerosis: Eight-Year Follow-up of an Integrated Analysis of DEFINE, CONFIRM, and ENDORSE
10.26226/morressier.59a3eda8d462b8028d895222
◽
2017
◽
Cited By ~ 1
Author(s):
Ralf Gold
Keyword(s):
Multiple Sclerosis
◽
Dimethyl Fumarate
◽
Integrated Analysis
◽
Newly Diagnosed
◽
Delayed Release
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Delayed-release Dimethyl Fumarate Demonstrated No Difference in Clinical Outcomes versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Real-world EFFECT Study
10.26226/morressier.59a3e8b6d462b8028d8951f5
◽
2017
◽
Cited By ~ 1
Author(s):
Jacob Sloane
Keyword(s):
Multiple Sclerosis
◽
Clinical Outcomes
◽
Real World
◽
Dimethyl Fumarate
◽
Effect Study
◽
The Real
◽
Delayed Release
◽
Relapsing Remitting
◽
Remitting Multiple Sclerosis
◽
Relapsing Remitting Multiple Sclerosis
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close